Scarica l'app Stockscreener
23.61
0.42%
-0.02
Precedente Chiudi:
$23.63
Aprire:
$23.53
Volume 24 ore:
112.78K
Relative Volume:
0.02
Capitalizzazione di mercato:
$11.79B
Reddito:
$4.89B
Utile/perdita netta:
$-242.00M
Rapporto P/E:
-48.28
EPS:
-0.489
Flusso di cassa netto:
$315.00M
1 W Prestazione:
-0.68%
1M Prestazione:
+4.53%
6M Prestazione:
+6.09%
1 anno Prestazione:
+74.81%
Intervallo 1D:
$23.42
$23.65
Intervallo di 1 settimana:
$22.83
$24.41
Portata 52W:
$13.15
$27.72
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
23.61 | 11.80B | 4.89B | -242.00M | 315.00M | -0.489 |
TAK
Takeda Pharmaceutical Co Adr
|
14.85 | 47.96B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.80 | 38.52B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
8.65 | 38.49B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
76.17 | 32.02B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
547.51 | 22.92B | 3.17B | 1.29B | 1.01B | 27.09 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Buy |
| 2026-01-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Aggiornamento | Argus | Hold → Buy |
| 2025-10-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
U.S. pet owners cut dining out before pet care, Elanco finds - Stock Titan
Peak Retirement Planning Inc. Acquires Shares of 121,770 Elanco Animal Health Incorporated $ELAN - MarketBeat
Geode Capital Management LLC Buys 640,098 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
BNP Paribas Financial Markets Purchases 2,193,391 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco (ELAN) CFO granted new deferred stock units under compensation plan - Stock Titan
Elanco (ELAN) officer Rajeev Modi receives deferred stock unit grant - Stock Titan
Elanco (ELAN) CEO Jeffrey Simmons granted new deferred stock units - Stock Titan
Legal & General Group Plc Has $17.68 Million Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
A Look At Elanco (ELAN) Valuation After Early Befrena Launch And Renewed Investor Optimism - Yahoo Finance
Elanco (ELAN) Is Up 9.8% After Launching Befrena, Its Second USDA-Approved Pet Biologic - Yahoo Finance
EBIT per share of Elanco Animal Health, Inc. – LS:A2N6BH - TradingView
Barclays Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Ribbon cut on $200 million Elanco animal health campus - MSN
Jupiter Asset Management Ltd. Trims Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Shareholders Back Board, Auditor and Executive Pay - The Globe and Mail
Jackson Creek Investment Advisors LLC Buys Shares of 65,370 Elanco Animal Health Incorporated $ELAN - MarketBeat
Royce & Associates LP Sells 107,638 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Northwestern Mutual Wealth Management Co. Grows Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health 2026 Shareholder Meeting Results: Board Elections and Executive Compensation Vote - Minichart
A Look at Elanco Animal Health Inc (ELAN) After 3.8% Gain -- GF Value $15.53 vs Price $23.69 - GuruFocus
Elanco (NYSE: ELAN) investors reelect board and ratify 2026 auditor - Stock Titan
Monumental Public-Private Initiative Forms to Permanently Close America’s Protein Gap - CSRwire
58,758 Shares in Elanco Animal Health Incorporated $ELAN Acquired by Williamson Legacy Group LLC - MarketBeat
A Look at Elanco Animal Health Inc (ELAN) After 5.0% Gain -- GF Value $15.53 vs Price $22.82 - GuruFocus
Board member at Elanco (NYSE: ELAN) granted new equity awards - Stock Titan
Elanco (NYSE: ELAN) director receives deferred and restricted stock units - Stock Titan
Elanco Animal Health (ELAN) director granted new equity awards - Stock Titan
[Form 4] Elanco Animal Health Inc Insider Trading Activity - Stock Titan
Elanco (NYSE: ELAN) director receives 4,678 deferred stock units - Stock Titan
Board member gets 4,678-share equity award at Elanco (NYSE: ELAN) - Stock Titan
Elanco (ELAN) director Harrington granted deferred and restricted stock units - Stock Titan
Elanco (ELAN) director granted stock and deferred unit awards as compensation - Stock Titan
Elanco (NYSE: ELAN) director Stacey Ma receives annual equity grants - Stock Titan
Elanco (NYSE: ELAN) director granted deferred and restricted stock units - Stock Titan
Elanco Animal Health (ELAN) Stock Analysis: Exploring Potential 37% Upside with Strong Buy Ratings - DirectorsTalk Interviews
Elanco Animal Health Incorporated (NYSE:ELAN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Q1 2026 Elanco Animal Health Inc Earnings Call Transcript - GuruFocus
Q1 Rundown: Elanco (NYSE:ELAN) Vs Other Pharmaceuticals Stocks - Yahoo Finance
ELAN Stock Price, Quote & Chart | ELANCO ANIMAL HEALTH INC (NYSE:ELAN) - ChartMill
Elanco Animal Health Inc Annual Shareholders Meeting Transcript - GuruFocus
Elanco Launches Befrena As New Dermatology Driver For Undervalued Shares - Yahoo Finance
Companion Animal Health Market is expected to Hit US$ 56.60 - openPR.com
Is Elanco Animal Health Inc (ELAN) Overvalued After 5.3% Rally? - GuruFocus
Is Elanco Animal Health Inc (ELAN) Overvalued After 5.3% Rally? GF Value Says Overvalued - GuruFocus
Elanco CEO Jeffrey Simmons buys $99,842 in company stock By Investing.com - Investing.com South Africa
Elanco EVP Rajeev Modi buys $99,938 of company stock By Investing.com - Investing.com South Africa
Elanco EVP Rajeev Modi buys $99,938 of company stock - Investing.com UK
Elanco CEO Jeffrey Simmons buys $99,842 in company stock - Investing.com UK
Elanco (NYSE: ELAN) officer Modi buys shares and receives deferred stock units - Stock Titan
Elanco (NYSE: ELAN) CEO adds shares and receives deferred units - Stock Titan
Elanco (NYSE: ELAN) CFO receives grant of deferred stock units as compensation - Stock Titan
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.22%
0.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):